Cargando…
The Anti-Tumorigenic Role of Cannabinoid Receptor 2 in Non-Melanoma Skin Cancer
Five million non-melanoma skin cancers occur globally each year, and it is one of the most common malignant cancers. The dysregulation of the endocannabinoid system, particularly cannabinoid receptor 2 (CB2), is implicated in skin cancer development, progression, and metastasis. Comparing wildtype (...
Autores principales: | Iden, Jennifer Ana, Raphael-Mizrahi, Bitya, Naim, Aaron, Kolomansky, Albert, Liron, Tamar, Neumann, Drorit, Vered, Marilena, Gabet, Yankel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178456/ https://www.ncbi.nlm.nih.gov/pubmed/37175480 http://dx.doi.org/10.3390/ijms24097773 |
Ejemplares similares
-
The Anti-Tumorigenic Role of Cannabinoid Receptor 2 in Colon Cancer: A Study in Mice and Humans
por: Iden, Jennifer Ana, et al.
Publicado: (2023) -
Erythropoietin Receptor (EPOR) Signaling in the Osteoclast Lineage Contributes to EPO-Induced Bone Loss in Mice
por: Awida, Zamzam, et al.
Publicado: (2022) -
The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in Mice
por: Awida, Zamzam, et al.
Publicado: (2021) -
Erythropoietin Mediated Bone Loss in Mice Is Dose-Dependent and Mostly Irreversible
por: Kolomansky, Albert, et al.
Publicado: (2020) -
Anti-CD20-Mediated B Cell Depletion Is Associated With Bone Preservation in Lymphoma Patients and Bone Mass Increase in Mice
por: Kolomansky, Albert, et al.
Publicado: (2020)